{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:20:38Z","timestamp":1777422038694,"version":"3.51.4"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Transdermal methimazole is an acceptable alternative to oral treatment for hyperthyroid cats. There are, however, no studies evaluating the duration of T4 suppression after transdermal methimazole application. Such information would be valuable for therapeutic monitoring.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess variation in serum T4 concentration in hyperthyroid cats after once- and twice-daily transdermal methimazole administration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Twenty client-owned cats with newly diagnosed hyperthyroidism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Methimazole was formulated in a pluronic lecithin organogel-based vehicle and applied to the pinna of the inner ear at a starting dose of 2.5 mg\/cat q12h (BID group, 10 cats) and 5 mg\/cat q24h (SID group, 10 cats). One and 3 weeks after starting treatment, T4 concentrations were measured immediately before and every 2 hours after gel application over a period of up to 10 hours.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Significantly decreased T4 concentrations were observed in week 1 and 3 compared with pretreatment concentrations in both groups. All cats showed sustained suppression of T4 concentration during the 10-hour period, and T4 concentrations immediately before the next methimazole treatment were not significantly different compared with any time point after application, either in the BID or SID groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Because transdermal methimazole application led to prolonged T4 suppression in both the BID and SID groups, timing of blood sampling does not seem to be critical when assessing treatment response.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jvim.12040","type":"journal-article","created":{"date-parts":[[2013,2,9]],"date-time":"2013-02-09T07:04:38Z","timestamp":1360393478000},"page":"377-381","source":"Crossref","is-referenced-by-count":12,"title":["Duration of T4 Suppression in Hyperthyroid Cats Treated Once and Twice Daily with Transdermal Methimazole"],"prefix":"10.1093","volume":"27","author":[{"given":"F.S.","family":"Boretti","sequence":"first","affiliation":[{"name":"Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich , Zurich,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.S.","family":"Sieber-Ruckstuhl","sequence":"additional","affiliation":[{"name":"Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich , Zurich,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Sch\u00e4fer","sequence":"additional","affiliation":[{"name":"Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich , Zurich,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Baumgartner","sequence":"additional","affiliation":[{"name":"Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich , Zurich,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Riond","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, Vetsuisse Faculty, University of Zurich , Zurich,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Hofmann-Lehmann","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, Vetsuisse Faculty, University of Zurich , Zurich,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.E.","family":"Reusch","sequence":"additional","affiliation":[{"name":"Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich , Zurich,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2013,3,1]]},"reference":[{"key":"2026020304244023300_jvim12040-bib-0001","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0195-5616(94)50060-3","article-title":"Considerations in the treatment of feline hyperthyroidism","volume":"24","author":"Kintzer","year":"1994","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"2026020304244023300_jvim12040-bib-0002","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0034-5288(91)90055-S","article-title":"Pharmacokinetics of methimazole in normal cats and cats with hyperthyroidism","volume":"50","author":"Trepanier","year":"1991","journal-title":"Res Vet Sci"},{"key":"2026020304244023300_jvim12040-bib-0003","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1098-612X(02)00095-5","article-title":"Transdermal methimazole treatment in cats with hyperthyroidism","volume":"5","author":"Hoffmann","year":"2003","journal-title":"J Feline Med Surg"},{"key":"2026020304244023300_jvim12040-bib-0004","first-page":"131","article-title":"Clinical efficacy and safety of transdermal methimazole in the treatment of feline hyperthyroidism","volume":"47","author":"Lecuyer","year":"2006","journal-title":"Can Vet J"},{"key":"2026020304244023300_jvim12040-bib-0005","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1939-1676.2004.tb02601.x","article-title":"Efficacy and safety of transdermal methimazole in the treatment of cats with hyperthyroidism","volume":"18","author":"Sartor","year":"2004","journal-title":"J Vet Intern Med"},{"key":"2026020304244023300_jvim12040-bib-0006","first-page":"162","volume-title":"Canine and Feline Endocrinology and Reproduction","author":"Feldmann","year":"2004","edition":"3rd ed"},{"key":"2026020304244023300_jvim12040-bib-0007","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1939-1676.2009.0370.x","article-title":"Optimal testing for thyroid hormone concentration after treatment with methimazole in healthy and hyperthyroid cats","volume":"23","author":"Rutland","year":"2009","journal-title":"J Vet Intern Med"},{"key":"2026020304244023300_jvim12040-bib-0008","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1365-2885.2002.00405.x","article-title":"Bioavailability of transdermal methimazole in a pluronic lecithin organogel (PLO) in healthy cats","volume":"25","author":"Hoffman","year":"2002","journal-title":"J Vet Pharmacol Ther"},{"key":"2026020304244023300_jvim12040-bib-0009","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1210\/jcem-57-1-129","article-title":"Intrathyroidal concentrations of methimazole in patients with Graves' disease","volume":"57","author":"Jansson","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"2026020304244023300_jvim12040-bib-0010","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1939-1676.2011.00799.x","article-title":"The efficacy and safety of a novel lipophilic formulation of methimazole for the once daily transdermal treatment of cats with hyperthyroidism","volume":"25","author":"Hill","year":"2011","journal-title":"J Vet Intern Med"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvim.12040","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvim.12040","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/27\/2\/377\/66684941\/jvim12040.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/27\/2\/377\/66684941\/jvim12040.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:24:54Z","timestamp":1770110694000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/27\/2\/377\/8451958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,1]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,3,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.12040","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,3]]},"published":{"date-parts":[[2013,3,1]]}}}